1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Stable Baseline Regimen: new trials by email Literature Review of Stable Baseline Regimen trials Research Report on Stable Baseline Regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1) Bictegravir, Lenacapavir, BIC/LEN FDC - HIV-1-infection | Phase 2 / Phase 3 | Active not recruiting | Gilead Sciences | 689 | 2022-08-16 | 2026-10-21 |
Gilead Sciences (1)
Argentina (1) · Australia (1) · Canada (1) · Dominican Republic (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Puerto Rico (1) · South Africa (1) · South Korea (1) · Spain (1) · Taiwan (1) · United Kingdom (1) · United States (1)